Active Pharmaceutical Ingredients Market Size Growing Rapidly, Report Includes Market Dynamics, Key Opportunities and Forecast 2027
Active
Pharmaceutical Ingredients Market is valued at USD 172.69 Billion in 2018 and
expected to reach USD 263.80 Billion by 2025 with the CAGR of 6.24% over the
forecast period.
Rising prevalence of chronic and infectious diseases such as
diabetes, cancer, arthritis, asthma chronic obstructive pulmonary disease
(COPD) bone & joint infections, pneumonia etc. with increased geriatric
population and surge in development of new drugs using active pharmaceutical
ingredients for fighting against such diseases are some important factor
driving the growth of this market.
Get Sample Copy of The Report@ https://brandessenceresearch.com/requestSample/PostId/51
** Sample pages for this report are
immediately accessible upon request. **
Scope of the Active Pharmaceutical Ingredients Market
Report:
Active
Pharmaceutical Ingredients (APIs) are portions of any drugs, which
are biologically active in nature. The APIs have significant use in the
manufacturing of effective and safe medicines. Depending on the drug’s
administered dosage, the reactions and results differ according to the
requirement and use for specific treatment of diseases. Certain drugs are
contained of more than one kind of API. Drugs are chosen primarily for their
active ingredients to treat a number of chronic and infectious diseases such as
diabetes, cancer, arthritis, bone & joint infections, pneumonia, otitis,
streptococcal pharyngitis, cellulites, and urinary tract infections. However,
the standard can vary widely from one brand to another. Drugs are chosen
primarily from active ingredients in the liquid or solid form like tablet or
other during formulation and development, the excipients are chosen can reach
the target site in the body at the desired rate and extent according to the
requirement.
Active pharmaceutical ingredients market is segmented on the
type of manufacturer, type of synthesis, type of drug, therapeutic application,
and region. Active pharmaceutical ingredients market is classified on the basis
of type of manufacturer are In-house, and contract base manufacturing. On the
basis of type of synthesis, the market is segmented as synthetic chemical,
classical fermentation, biotech/biological, plant extracts, and others. On the
basis of type of drugs, global active pharmaceutical ingredients market is
divided into innovative prescription drugs, generic prescription drugs and
others. On the basis of therapeutic application cardiovascular drugs, metabolic
disorders drugs, oncology drugs, central nervous system drugs, anti-infective
drugs, respiratory diseases drugs and others.
The regions covered in global active pharmaceutical
ingredients market report are North America, Europe, Asia-Pacific and Rest of
the World. On the basis of country level, Global Melanoma Drug Market sub
divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan,
India, South East Asia, GCC, Africa, etc.
Active Pharmaceutical Ingredients services Companies:
- Sun
Pharmaceutical Industries Ltd.
- Pfizer
Inc.
- Teva
Pharmaceutical Industries Ltd.
- Aurobindo
Pharma
- Novartis
AG
- Merck
& Co.
- Boehringer
Ingelheim International GmbH.
- Bayer
AG
- F.
Hoffmann-La Roche Ltd
Global Active Pharmaceutical Ingredients Market Dynamics –
The key factor for growth of global active pharmaceutical
ingredients market is the rise of demand for the new drug discovery for
treatment of various chronic and infectious diseases like HIV, cancer,
arthritis, bone & joint infections, hepatitis-B, Aids etc. across the
globe. According to WHO in 2018, the global cancer burden has risen to 18.1
million new cases including 9.6 million deaths across the globe. Due to such
rise in the cases of cancer, the new drugs discovery using the active
pharmaceutical ingredients has became essential. Recently according to the
American Chemical Society in 2019, there has been 48 new drugs has been approved
by the FDA U.S. out of which 11 for new cancer treatments with the innovative
molecular pharmaceutical ingredients. However, the active pharmaceutical
ingredients market is hampered by need for high investment with huge capital
requirement for research and developments. Moreover rising health cautiousness
among the people with technological advancement huge investment for launching
of new drugs and biological products, acquisitions, collaborations, and
regional expansion will provide huge opportunity for active pharmaceutical
ingredients market. For instance in 2019, ArQule has been acquired by Merck
& Co. for roughly around USD 2.7 billion in cash, for making cancer drug
using active pharmaceutical ingredients with the latest small-molecule-focused.
Active Pharmaceutical Ingredients Market Regional
Analysis –
North America is expected to dominate the active
pharmaceutical ingredients market with the potential rate as
presence of pharmaceutical companies for new drug discovery using advanced
technology in this region. According to the International Federation of
Pharmaceutical Manufacturers & Associations (IFPMA), the U.S. holds 45%
global market share for pharmaceutical companies including new drug discovery
using the active pharmaceutical ingredients with spending has been increased
from USD 461.7 billion in 2016 to USD 645-675 billion in 2021, while the
European share of pharmaceutical drug development spending will grow from USD
151.8 billion to USD 170-200 billion from 2016 to 2021 year. Europe is the
second-largest region for dominating the growth of active pharmaceutical
ingredients due to rise of infectious diseases like Corona virus, HIV, etc.
The Asia Pacific is expected to emerge as the
fastest-growing regional market due to rapidly increasing the prevalence of
therapeutic and chronic diseases i.e., diabetes, cancer etc. with rising
population in this region. According to WHO, around 65% of all cancer deaths
occur in developing countries and the number of global cancer deaths is
projected to increase by 45 percent from 2007 to 2030 with from 7.9 million to
11.5 million deaths influenced by rise in consumption of tobacco use, unhealthy
diet, insufficient physical activity and the harmful use of alcohol in this
region.
Get Methodology Of The Report @ https://brandessenceresearch.com/requestMethodology/PostId/51
Key Benefits for Active Pharmaceutical Ingredients
Market Reports –
Global Active Pharmaceutical Ingredients market report
covers in depth historical and forecast analysis.
Global Active Pharmaceutical Ingredients market research
report provides detail information about market introduction, market summary,
global market revenue (revenue USD), market drivers, market restraints, market
opportunities, competitive analysis, regional and country level.
Global Active Pharmaceutical Ingredients market report helps
to identify opportunities in market place.
Global Active Pharmaceutical Ingredients market report
covers extensive analysis of emerging trends and competitive landscape.
Active Pharmaceutical Ingredients
Market Segmentation –
by Type of Manufacturer - In-house
manufacturing, Contract base manufacturing
by Type of synthesis - Fermentation,
Biotech/biological, Plant extracts, Others
by Type of Drugs - Innovative prescription
drugs, Generic prescription drugs
by Therapeutic Application - Cardiovascular drugs,
Metabolic disorders drugs, Oncology drugs, Central nervous system drugs,
Anti-infective drugs, Respiratory diseases drugs, Others
Active Pharmaceutical Ingredients Market: by Regional
& Country Analysis
North America, US, Mexico, Chily, Canada, Europe, UK,
France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India,
Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa,
Rest of Middle East and Africa
Get Full Report :@ https://brandessenceresearch.com/pharmaceutical/global-active-pharmaceutical-ingredients-market-2018-2024
Related Report :
Comments
Post a Comment